Synbiotic Therapy: a Promising New Adjunctive Therapy for Ulcerative Colitis.
From: College of Pharmacy and Nutrition, University of Saskatchewan Saskatoon, Saskatchewan, Canada.
Nutrition reviews
- Publish Date: Mar 2006
- ISSN: 0029-6643
- Volume: 64
- Issue: 3
- Pages: 132-8
- Medium: Print
- Language: English
- Citation (JAMA): Haskey Natasha, Dahl Wendy J, et al. Synbiotic Therapy: a Promising New Adjunctive Therapy for Ulcerative Colitis.. Nutr. Rev. Mar 2006;64:132-8
Abstract
Prebiotic and probiotic therapies are new strategies being used to treat gastrointestinal diseases. Recent evidence suggests that the administration of select prebiotics and probiotics, alone or in combination (the latter called “synbiotic” therapy) may improve the clinical outcome of patients with ulcerative colitis. We report a case of a pediatric ulcerative colitis patient who showed increased length of remission, resolution of symptoms, and improved quality of life following the administration of synbiotic therapy. The literature supporting the use of prebiotic, probiotic, and synbiotic therapies in adult ulcerative colitis is also reviewed.
Mesh Headings (Keywords): Bifidobacterium, Colitis, Ulcerative, Humans, Intestines, Probiotics, Quality of Life, Treatment Outcome
Check for Full Text / PubMed Unique Identifier (PMID): 16572600
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.